Publications
⭐NEW⭐ just published!!!
De Mitri F, Giansanti M, Melaiu O, Haas D, Ebert S, Tumino N, Vulpis E, Gatto F, Martuscelli B, Antonioli M, Sangiuliano E, Caruso S, Marco S, De Stefanis C, Marabitti V, Campello S, Fruci D, Vacca P, Caruana I, Nazio F. Inhibition of autophagy enhances the antitumor efficacy of T/CAR T cell against neuroblastoma. J Exp Clin Cancer Res. 2025 Jul 3;44(1):185. doi: 10.1186/s13046-025-03453-0.
Foti A, Allia F, Briglia M, Malaguarnera R, Tamburrini G, Cecconi F, Pagliarini V, Nazio F, Graziano ACE. Medulloblastoma: Molecular Targets and Innovative Theranostic Approaches. Pharmaceutics. 2025 Jun 4;17(6):736. doi: 10.3390/pharmaceutics17060736.
Marabitti V, Vulpis E, Nazio F*, Campello S*. Mitochondrial Transfer as a Strategy for Enhancing Cancer Cell Fitness:Current Insights and Future Directions. Pharmacol Res. 2024 Oct;208:107382. doi: 10.1016/j.phrs.2024.107382.
Ciccone R, Quintarelli C, Camera A, Pezzella M, Caruso S, Manni S, Ottaviani A, Guercio M, Del Bufalo F, Quadraccia MC, Orlando D, Di Cecca S, Sinibaldi M, Aurigemma M, Iaffaldano L, Sarcinelli A, D'Amore ML, Ceccarelli M, Nazio F, Marabitti V, Giorda E, Pezzullo M, De Stefanis C, Carai A, Rossi S, Alaggio R, Del Baldo G, Becilli M, Mastronuzzi A, De Angelis B, Locatelli F. GD2-Targeting CAR T-cell Therapy for Patients with GD2+ Medulloblastoma. Clin Cancer Res. 2024 Jun 3;30(11):2545-2557. doi: 10.1158/1078-0432.CCR-23-1880.
Salvatori I, Nesci V, Spalloni A, Marabitti V, Muzzi M, Zenuni H, Scaricamazza S, Rosina M, Fenili G, Goglia M, Boffa L, Massa R, Moreno S, Mercuri NB, Nazio F, Longone P, Ferri A, Valle C. Trimetazidine Improves Mitochondrial Dysfunction in SOD1G93A Cellular Models of Amyotrophic Lateral Sclerosis through Autophagy Activation. Int J Mol Sci. 2024 Mar 13;25(6):3251. doi: 10.3390/ijms25063251.
Giansanti M, Theinert T, Boeing SK, Haas D, Schlegel PG, Vacca P, Nazio F*, Caruana I*. Exploiting autophagy balance in T and NK cells as a new strategy to implement adoptive cell therapies. Mol Cancer. 2023 Dec 9;22(1):201. doi: 10.1186/s12943-023-01893-w.
Pagliara D, Ciolfi A, Pedace L, Haghshenas S, Ferilli M, Levy MA, Miele E, Nardini C, Cappelletti C, Relator R, Pitisci A, De Vito R, Pizzi S, Kerkhof J, McConkey H, Nazio F, Kant SG, Di Donato M, Agolini E, Matraxia M, Pasini B, Pelle A, Galluccio T, Novelli A, Barakat TS, Andreani M, Rossi F, Mecucci C, Savoia A, Sadikovic B, Locatelli F, Tartaglia M. Identification of a robust DNA methylation signature for Fanconi anemia. Am J Hum Genet. 2023 Nov 2;110(11):1938-1949. doi: 10.1016/j.ajhg.2023.09.014.
Marabitti V, Caruana I, Nazio F. Should I stay or should I go? Spatio-temporal control of cellular anchorage by hematopoietic factors orchestrates tumor metastatic cascade. Mol Cancer. 2023 Sep 7;22(1):149. doi: 10.1186/s12943-023-01851-6.
Pitolli C, Marini A, Guerra M, Pieraccioli M, Marabitti V, Palluzzi F, Giacò L, Tamburrini G, Cecconi F, Nazio F, Sette C, Pagliarini V. MYC up-regulation confers vulnerability to dual inhibition of CDK12 and CDK13 in high-risk Group 3 medulloblastoma. J Exp Clin Cancer Res. 2023 Aug 21;42(1):214. doi: 10.1186/s13046-023-02790-2..
Marabitti V, Giansanti M, De Mitri F, Gatto F, Mastronuzzi A, Nazio F. Pathological implications of metabolic reprogramming and its therapeutic potential in medulloblastoma. Front Cell Dev Biol. 2022 Oct 19;10:1007641. doi: 10.3389/fcell.2022.1007641.